SANTA ANA, Calif., Feb. 28, 2024 /PRNewswire/ -- Autonomous Medical Devices Incorporated (AMDI) has received a National Institutes of Health (NIH) RADx Tech award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), part of the NIH. Up to $5.2 million in funding will be used by AMDI to complete development of its Fast PCR System, a CLIA-waivable RT-PCR point-of-care system that can detect up to 32 targets per sample in less than 10 minutes.

加利福尼亚州圣安娜，2024年2月28日/PRNewswire/--自主医疗器械公司（AMDI）获得了美国国立卫生研究院生物医学成像与生物工程研究所（NIBIB）授予的美国国立卫生研究院（NIH）RADx技术奖，NIH是NIH的一部分。AMDI将使用高达520万美元的资金来完成其快速PCR系统的开发，这是一个CLIA Waiable RT-PCR即时护理系统，可以在不到10分钟的时间内检测每个样品多达32个靶标。

The funding will also be used to complete the first test panel for the Fast PCR system, targeting detection of multiple respiratory viruses: Influenza A and B, respiratory syncytial virus (RSV), and SARS-CoV-2..

这笔资金还将用于完成快速PCR系统的第一个测试小组，目标是检测多种呼吸道病毒：甲型和乙型流感，呼吸道合胞病毒（RSV）和SARS-CoV-2。。

The RADx Tech program was created to speed innovation and address critical public health challenges like the COVID-19 pandemic. AMDI's selection of an additional award, after timely and successful completion of its previous award, underscores the continued market need and the potential of a cloud connected, multiplex point-of-care device..

RADx技术计划旨在加快创新速度，应对新冠肺炎等重大公共卫生挑战。AMDI在及时且成功地完成了之前的奖项后，选择了一个额外的奖项，这突显了云连接的多重护理点设备的持续市场需求和潜力。。

'AMDI is grateful for the recognition by the NIBIB for a second award that gives us the opportunity to complete the development of the Fast PCR System,' said David Okrongly, CEO of AMDI. 'Our market research indicates that our technology, when combined with cloud connectivity, can revolutionize patient care in the CLIA Waived setting.'.

AMDI首席执行官大卫·奥克隆利（DavidOkrongly）说：“AMDI感谢NIBIB对第二个奖项的认可，这给了我们完成快速PCR系统开发的机会。”我们的市场研究表明，当我们的技术与云连接相结合时，可以在放弃CLIA的情况下彻底改变患者护理。”。

'The core of our system is the Hyperbaric Heating (HBH) sample prep technology combined with our ultrafast PCR chemistry. The HBH technology removes the time constraints and costs associated with traditional sample prep', said Regis Peytavi, CTO of AMDI. 'Combining HBH with our ultrafast thermal cycling allows us to stay under 10 minutes regardless of the number of targets we put on the test disc.'.

“我们系统的核心是高压加热（HBH）样品制备技术与我们的超快PCR化学相结合。HBH技术消除了与传统样品制备相关的时间限制和成本”，AMDI首席技术官Regis Peytavi说。“将HBH与我们的超快热循环相结合，无论我们在测试盘上放置多少个目标，我们都可以保持在10分钟以下。”。

This project has been funded in part with Federal funds from the National Institute of Biomedical Imaging (NIBIB), National Institutes of Health, Department of Health and Human Services, under Contract No. 75N92023D00001.

根据75N92023D00001号合同，该项目部分由美国国立生物医学成像研究所（NIBIB）、美国国立卫生研究院、卫生与公众服务部的联邦资金资助。

About AMDI

关于AMDI

Autonomous Medical Devices Incorporated (AMDI) is a California company employing a world class team of engineers, scientists, clinicians, and manufacturing experts dedicated to the development and manufacture of best-in-class point-of-care diagnostic devices using innovative technology, factory automation, and cloud connectivity.

Autonomous Medical Devices Incorporated（AMDI）是加利福尼亚州的一家公司，拥有世界一流的工程师、科学家、临床医生和制造专家团队，致力于使用创新技术、工厂自动化和云连接开发和制造一流的即时诊断设备。

AMDI is headquartered in Santa Ana, CA where it manufactures its test cartridges in an ISO:13485 certified 110,000 square foot facility..

AMDI总部位于加利福尼亚州圣安娜，在那里它在一个ISO:13485认证的110000平方英尺的设施中生产测试墨盒。。

Media contact: Brian Millermedia@amdilabs.com

媒体联系人：BrianMillermedia@amdilabs.com

SOURCE Autonomous Medical Devices Incorporated

SOURCE Autonomous Medical Devices Incorporated公司